American Shared Hospital Services (AMS)
AMEXHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$1.43-2.05%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
Intact: The reason to own it still holds.
AMS rents radiosurgery equipment to hospitals. Cash from operations rose to $2.1M in 2026-Q1. The company aims to expand clinical capacity and partnerships. This could help sales grow and improve finances.
AMS lost money recently and missed earnings several times. The CEO left in 2026. Revenue is expected to shrink about 4% next year. These problems could continue or get worse.
The market expects about 4% revenue decline next year. Our fair value is $3.9, reflecting this weak outlook. We see some chance of recovery but risks remain high.
Breaks if: Cash from operations falls below $2.1M in 2026-Q1
Breaks if: Another CEO leaves or major leadership disruption occurs in 2026
Revenue falls below $7.1M in 2026-Q2
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
AMS is a speculative growth investment with a focus on expanding its clinical capacity and procedure volumes. The current thesis is cautious, reflecting recent earnings misses and volatility in management.
The market appears to have priced in a low valuation compared to peers, indicating that expectations are not overly optimistic. However, there is a significant gap in expectations, suggesting that the market is not fully confident in a turnaround.
Management is making progress in growing procedure volumes and improving cash flow, but recent financial performance has been weak. The near-term risk is elevated, with a notable probability of missing earnings expectations.
The thesis hinges on management's ability to maintain momentum in procedure growth and improve financial stability. Additionally, the performance of sector leaders and broader economic conditions will play a crucial role in AMS's outlook.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. Strong revenue growth supports the read. This indicates growth in procedure volumes and new installations. However, the latest earnings miss poses a threat. This miss raises concerns about future performance.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, AMS's performance will depend on effective execution of its growth strategies and external market conditions. Not investment advice.